The action camera maker said demand was weak over the holidays, and said it's lowering its forecast and cutting jobs. Celgene Corp., down 81 cents to $104.18. The biotech drugmaker said it will buy Impact Biomedicines for $1.1 billion, with up to $5.9 billion in other potential payments.
News
- Celgene, Dave & Buster's slide while Kohl's and Crocs rise
- bioAffinity Technologies to Present at Biotech Showcase™ Annual Conference
SAN ANTONIO, Texas, Jan. 05, 2018 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, today announced that it will present its proprietary technology to detect and treat multiple cancers at the cellular level at Biotech Showcase™ 2018, an annual investor…
- Promising SA biotech to get global audience with potential investors
A San Antonio-based biotech companies has secured an invitation to a West Coast event that could elevate it from a promising upstart to a player on the international stage. BioAffinity Technologies, a privately held cancer diagnostics company that moved its headquarters to San Antonio in March…
- Dow 25000: Index keeps rolling with another milestone
This tamale-making hack may change your next tamalada... mysa; Dog caught in middle of family's New Year's Eve fireworks... mysa; San Antonio child sings ... The Nasdaq composite, which is heavily weighted with technology and biotech companies, added 12.38 points, or 0.2 percent, to 7,077.91.…
- Business Highlights
The Nasdaq composite, which is heavily weighted with technology and biotech companies, added 12.38 points, or 0.2 percent, to 7,077.91. Benchmark U.S. crude rose 38 cents to $62.01 a barrel in New York. Brent crude, used to price international oils, added 23 cents to $68.07 a barrel in London.…